Photo of Tammy Baldwin
D United States Senate · Wisconsin

Sen. Tammy Baldwin

Compare
Total votes
1,044
all sessions
Attendance
100%
2 missed
Higher than 92% of chamber peers
With party
97%
of cast votes
Near the chamber average
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
1,680
bills & resolutions
Near the chamber average
Committees
15
assignments
1,680 bills and resolutions

Sponsored bills

Total
1,680
Primary
191
Co-sponsor
1,489
This page
1,680
matching current filters
Co-sponsor S 3213
In committee · United States Senate · Co-sponsor
IDEA Full Funding Act

IDEA Full Funding Act This bill provides permanent, mandatory funding for the grant program that assists states and outlying areas in providing special education and related services to children with disabilities.

In committee Nov 16, 2021 1 co-sponsor
Co-sponsor SRES 441
Passed · United States Senate · Co-sponsor
A resolution designating November 6, 2021, as "National Bison Day".

Maddy summarySRES 441 designates November 6, 2021, as National Bison Day to recognize the historical, cultural, and economic significance of bison in the United States. The resolution encourages the American public to observe the day with ceremonies and activities, building on an annual tradition that began in 2012. It highlights bison's role in Native American heritage, conservation efforts, and contributions to rural economies, without creating new legal requirements or funding.

Passed Nov 4, 2021 1 co-sponsor
Co-sponsor S 3191
In committee · United States Senate · Co-sponsor
Everyday Philanthropist Act

Everyday Philanthropist Act This bill allows employers to offer certain employees a tax-advantaged flexible giving account as a fringe benefit. Flexible giving accounts allow employees to set aside up to $2,700 of their annual pretax earnings to make tax-deductible charitable contributions without having to itemize tax deductions.

In committee Nov 4, 2021 1 co-sponsor
Co-sponsor S 4
Introduced · United States Senate · Co-sponsor
John R. Lewis Voting Rights Advancement Act of 2021

John R. Lewis Voting Rights Advancement Act of 2021 This bill establishes new criteria for determining which states and political subdivisions must obtain preclearance before changes to voting practices may take effect. Preclearance is the process of receiving preapproval from the Department of Justice (DOJ) or the U.S. District Court for the District of Columbia before making legal changes that would affect voting rights. The bill also includes provisions related to federally protected activities at polling places and voting access on tribal lands. A state and all of its political subdivisions shall be subject to preclearance of voting practice changes for a 10-year period if 15 or more voting rights violations occurred in the state during the previous 25 years; or 10 or more violations occurred during the previous 25 years, at least 1 of which was committed by the state itself. A political subdivision as a separate unit shall also be subject to preclearance for a 10-year period if three or more voting rights violations occurred there during the previous 25 years. States and political subdivisions that meet certain thresholds regarding minority groups must preclear covered practices before implementation, such as changes to methods of election and redistricting. Further, states and political subdivisions must notify the public of changes to voting practices. Next, the bill authorizes DOJ to require states or political subdivisions to provide certain documents or answers to questions for enforcing voting rights. The bill also outlines factors courts must consider when hearing challenges to voting practices, such as the history of official voting discrimination in the state or political subdivision. In addition, the bill (1) includes certain protections for election workers, polling places, and election infrastructure; and (2) expands voting access on tribal lands.

Introduced Nov 3, 2021 1 co-sponsor
Co-sponsor S 3139
In committee · United States Senate · Co-sponsor
Healthy Competition for Better Care Act

Healthy Competition for Better Care Act This bill generally prohibits agreements between health insurance plans and provider networks that (1) restrict an insurance plan from offering incentives for enrollees to use specific providers, (2) require a plan to enter into additional agreements with an affiliate of the provider network, or (3) require a plan to agree to certain payment rates or other terms with entities that are not a party to the contract.

In committee Nov 2, 2021 1 co-sponsor
Co-sponsor S 3098
In committee · United States Senate · Co-sponsor
Preventive Care Awareness Act of 2021

Preventive Care Awareness Act of 2021 This bill requires the Department of Health and Human Services (HHS) to promote the use of preventive health care services. In particular, HHS must focus on decreasing disparities in accessing preventive services for individuals in rural and underserved communities who delayed or forewent recommended preventive services during the COVID-19 pandemic. Specifically, HHS must carry out a campaign to increase public awareness about and use of recommended preventive services. HHS must also convene a task force to develop recommendations regarding preventive services during and after the COVID-19 pandemic and future pandemics. The recommendations must address, among other considerations, reducing disparities in health outcomes and identifying barriers to implementing the recommendations. Additionally, the Centers for Disease Control and Prevention must provide grants to states, tribes and providers of tribal health services, territories, and localities for increasing patient uptake of recommended preventive services.

In committee Oct 28, 2021 1 co-sponsor
Co-sponsor S 3080
In committee · United States Senate · Co-sponsor
Cancer Drug Parity Act of 2021

Cancer Drug Parity Act of 20 21 This bill requires group health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration. To comply with this requirement, plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.

In committee Oct 27, 2021 1 co-sponsor
Co-sponsor SRES 408
Passed · United States Senate · Co-sponsor
A resolution designating October 2021 as "National Co-op Month" and commending the cooperative business model and the member-owners, businesses, employees, farmers, ranchers, and practitioners who use the cooperative business model to positively impact the economy and society.

This resolution designates October 2021 as National Co-Op Month, commends the cooperative business model for its contributions to the economy, and expresses confidence in cooperatives to continue their successes.

Passed Oct 21, 2021 1 co-sponsor
Co-sponsor S 3050
In committee Oct 21, 2021 1 co-sponsor
Showing 1,291 to 1,300 of 1,680 bills